Molecular interactions of Bcl-2 and Bcl-xL with mortalin: identification and functional characterization

Nishant Saxena1, Shashank P Katiyar2, Ye Liu1

  • 1*National Institute of Advanced Industrial Science and Technology (AIST), Central 4, 1-1-1 Higashi, Tsukuba Science City 305-8562, Japan.

Bioscience Reports
|September 21, 2013
PubMed

Insights

The Bcl-2 family proteins interact with mortalin, disrupting mortalin-p53 binding. This interaction reactivates p53, inducing senescence in cancer cells.

Area of Science:

  • Molecular biology
  • Cell biology
  • Biochemistry

Background:

  • The Bcl-2 protein family regulates apoptosis through mitochondrial pathways.
  • Mortalin, a stress chaperone, interacts with p53, influencing its function.
  • Mitochondrial outer membrane permeabilization is critical for apoptosis.

Purpose of the Study:

  • To investigate the interaction between Bcl-2 family proteins and mortalin.
  • To elucidate the functional consequences of this interaction on p53.
  • To explore the potential of targeting this interaction for cancer therapy.

Main Methods:

  • Bioinformatic analysis to predict interactions.
  • Biochemical assays to confirm protein interactions.
  • Cellular assays to assess p53 localization and transcriptional activity.
  • Senescence induction assays in cancer cells.

Main Results:

  • Bcl-2 and Bcl-xL directly interact with mortalin.
  • This interaction abrogates the mortalin-p53 complex.
  • Disruption of mortalin-p53 interaction leads to p53 nuclear translocation.
  • Reactivated p53 induces senescence in cancer cells.

Conclusions:

  • Bcl-2 and Bcl-xL binding to mortalin disrupts its interaction with p53.
  • This mechanism promotes p53 nuclear accumulation and transcriptional activity.
  • Targeting the Bcl-2-mortalin interaction may offer a novel strategy for cancer treatment by inducing senescence.